Hypertension impairs neurovascular coupling and promotes microvascular injury: role in exacerbation of Alzheimer’s disease

[1]  Grant R. Gordon,et al.  Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline , 2017, Experimental Gerontology.

[2]  A. Heerschap,et al.  Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  S. Vallabhajosula,et al.  Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET , 2017, American Journal of Neuroradiology.

[4]  X. Tong,et al.  Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1 , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  U. Sengupta,et al.  Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies , 2017, Aging and disease.

[6]  Z. Ungvari,et al.  IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan , 2017, GeroScience.

[7]  Judith Campisi,et al.  Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells , 2017, GeroScience.

[8]  D. Promislow,et al.  A randomized controlled trial to establish effects of short-term rapamycin treatment in 24 middle-aged companion dogs , 2017, GeroScience.

[9]  Olivier Beauchet,et al.  Cognitive status, fast walking speed and walking speed reserve—the Gait and Alzheimer Interactions Tracking (GAIT) study , 2017, GeroScience.

[10]  S. Espinoza,et al.  A new mouse model of frailty: the Cu/Zn superoxide dismutase knockout mouse , 2017, GeroScience.

[11]  S. Tarantini,et al.  Cerebral microhemorrhages: mechanisms, consequences, and prevention. , 2017, American journal of physiology. Heart and circulatory physiology.

[12]  Cory B. Giles,et al.  Insulin‐like growth factor 1 deficiency exacerbates hypertension‐induced cerebral microhemorrhages in mice, mimicking the aging phenotype , 2017, Aging cell.

[13]  B. Miller,et al.  Influence of Nrf2 activators on subcellular skeletal muscle protein and DNA synthesis rates after 6 weeks of milk protein feeding in older adults , 2017, GeroScience.

[14]  K. Rockwood,et al.  The association between frailty, the metabolic syndrome, and mortality over the lifespan , 2017, GeroScience.

[15]  Nadine C. Heyworth,et al.  Microglia activation and phagocytosis: relationship with aging and cognitive impairment in the rhesus monkey , 2017, GeroScience.

[16]  Z. Ungvari,et al.  The GH/IGF-1 axis in a critical period early in life determines cellular DNA repair capacity by altering transcriptional regulation of DNA repair-related genes: implications for the developmental origins of cancer , 2017, GeroScience.

[17]  P. Bickford,et al.  Neuroprotective mechanisms of astaxanthin: a potential therapeutic role in preserving cognitive function in age and neurodegeneration , 2017, GeroScience.

[18]  T. Kiss,et al.  Cerebromicrovascular dysfunction predicts cognitive decline and gait abnormalities in a mouse model of whole brain irradiation-induced accelerated brain senescence , 2017, GeroScience.

[19]  Y. Pai,et al.  Retention of the “first-trial effect” in gait-slip among community-living older adults , 2017, GeroScience.

[20]  R. Truscott,et al.  The phospholipid composition of the human entorhinal cortex remains relatively stable over 80 years of adult aging , 2017, GeroScience.

[21]  B. Gaszner,et al.  Age-related changes in central effects of corticotropin-releasing factor (CRF) suggest a role for this mediator in aging anorexia and cachexia , 2017, GeroScience.

[22]  J. Kopchick,et al.  The role of transplanted visceral fat from the long-lived growth hormone receptor knockout mice on insulin signaling , 2017, GeroScience.

[23]  M. Lindsey,et al.  The impact of aging on cardiac extracellular matrix , 2017, GeroScience.

[24]  K. Cherry,et al.  The frailty index outperforms DNA methylation age and its derivatives as an indicator of biological age , 2017, GeroScience.

[25]  D. Promislow,et al.  Asymptomatic heart valve dysfunction in healthy middle-aged companion dogs and its implications for cardiac aging , 2017, GeroScience.

[26]  R. Kohanski,et al.  Geroscience and the trans-NIH Geroscience Interest Group, GSIG , 2017, GeroScience.

[27]  Cory B. Giles,et al.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging , 2016, AGE.

[28]  Michelle R. Caunca,et al.  Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study , 2016, Journal of the American Heart Association.

[29]  M. Hart,et al.  Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[30]  B. Zlokovic,et al.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[31]  E. Mark Haacke,et al.  Increased Number and Distribution of Cerebral Microbleeds Is a Risk Factor for Cognitive Dysfunction in Hemodialysis Patients , 2016, Medicine.

[32]  B. Zlokovic,et al.  Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  C. Iadecola,et al.  Hypertension enhances Aβ-induced neurovascular dysfunction, promotes β-secretase activity, and leads to amyloidogenic processing of APP , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  Wei Zhang,et al.  Rapamycin rescues vascular, metabolic and learning deficits in apolipoprotein E4 transgenic mice with pre-symptomatic Alzheimer’s disease , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  Harald Sontheimer,et al.  Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease. , 2015, Brain : a journal of neurology.

[36]  S. Tarantini,et al.  Aging Exacerbates Pressure-Induced Mitochondrial Oxidative Stress in Mouse Cerebral Arteries. , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  F. Deák,et al.  Pharmacologically-Induced Neurovascular Uncoupling is Associated with Cognitive Impairment in Mice , 2015, Journal of Cerebral Blood Flow and Metabolism.

[38]  Alejandro F Frangi,et al.  Vascular dysfunction in the pathogenesis of Alzheimer's disease — A review of endothelium-mediated mechanisms and ensuing vicious circles , 2015, Neurobiology of Disease.

[39]  J. Hardy,et al.  Neurobiology of Alzheimer’s Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive Dimensions , 2015, Current Alzheimer research.

[40]  A. Richardson,et al.  How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story , 2015, Experimental Gerontology.

[41]  S. Tarantini,et al.  IGF‐1 deficiency impairs neurovascular coupling in mice: implications for cerebromicrovascular aging , 2015, Aging cell.

[42]  Benno Gesierich,et al.  Dysfunction of Mouse Cerebral Arteries during Early Aging , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[43]  Masanori Ichise,et al.  Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated , 2015, Neuroscience Letters.

[44]  Simon C. Cork,et al.  A Critical Role for Purinergic Signalling in the Mechanisms Underlying Generation of BOLD fMRI Responses , 2015, The Journal of Neuroscience.

[45]  S. Smaniotto,et al.  Combined Effect of Insulin-Like Growth Factor-1 and CC Chemokine Ligand 2 on Angiogenic Events in Endothelial Cells , 2015, PloS one.

[46]  S. Tarantini,et al.  IGF‐1 Deficiency Exacerbates Hypertension‐Induced Cerebral Microhemorrhages in Mice, Mimicking the Aging Phenotype , 2015 .

[47]  D. Sosnowska,et al.  Age‐Related Decline of Autocrine Pituitary Adenylate Cyclase‐Activating Polypeptide Impairs Angiogenic Capacity of Rat Cerebromicrovascular Endothelial Cells , 2015, The journals of gerontology. Series A, Biological sciences and medical sciences.

[48]  Jesse D. Sengillo,et al.  GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration , 2015, Nature Neuroscience.

[49]  Cory B. Giles,et al.  Aging exacerbates hypertension-induced cerebral microhemorrhages in mice: role of resveratrol treatment in vasoprotection , 2015, Aging cell.

[50]  G. Joshi,et al.  Increased Alzheimer's disease–like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy , 2015, Neurobiology of Aging.

[51]  Arthur W. Toga,et al.  Blood-Brain Barrier Breakdown in the Aging Human Hippocampus , 2015, Neuron.

[52]  Cory B. Giles,et al.  Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  K. Abe,et al.  Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[54]  Cory B. Giles,et al.  Caloric Restriction Confers Anti‐Oxidative, Pro‐Angiogenic, and Anti‐Inflammatory Effects and Promotes Anti‐Aging miRNA Expression Profile in Cerebromicrovascular Endothelial Cells of Aged Rats , 2014, American journal of physiology. Heart and circulatory physiology.

[55]  C. Iadecola.  Hypertension and dementia. , 2014, Hypertension.

[56]  R. Marr,et al.  Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance , 2014, Front. Aging Neurosci..

[57]  Matthew B. Bouchard,et al.  A Critical Role for the Vascular Endothelium in Functional Neurovascular Coupling in the Brain , 2014, Journal of the American Heart Association.

[58]  Ping Zhou,et al.  Age-Dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy , 2014, Stroke.

[59]  P. Wolf,et al.  Risk Factors, Stroke Prevention Treatments, and Prevalence of Cerebral Microbleeds in the Framingham Heart Study , 2014, Stroke.

[60]  Olivier Salvado,et al.  Incidence of cerebral microbleeds in preclinical Alzheimer disease , 2014, Neurology.

[61]  S. Tarantini,et al.  Aging Impairs Myogenic Adaptation to Pulsatile Pressure in Mouse Cerebral Arteries , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[62]  Rong Zhang,et al.  Dynamic cerebral autoregulation and tissue oxygenation in amnestic mild cognitive impairment. , 2014, Journal of Alzheimer's disease : JAD.

[63]  D. Sosnowska,et al.  IGF-1 Deficiency Impairs Cerebral Myogenic Autoregulation in Hypertensive Mice , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[64]  D. Sosnowska,et al.  Cardiovascular and Cerebrovascular Aging–New Mechanisms and Insights: Resveratrol treatment rescues neurovascular coupling in aged mice: role of improved cerebromicrovascular endothelial function and downregulation of NADPH oxidase , 2014 .

[65]  X. Tong,et al.  Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice , 2014, Neurobiology of Aging.

[66]  Arthur F. Kramer,et al.  Neurovascular coupling in normal aging: A combined optical, ERP and fMRI study , 2014, NeuroImage.

[67]  B. Zlokovic,et al.  Pericyte loss influences Alzheimer-like neurodegeneration in mice , 2013, Nature Communications.

[68]  D. Hinton,et al.  Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology , 2013, Journal of neurochemistry.

[69]  C. Oliveira,et al.  Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells. , 2013, Biochimica et biophysica acta.

[70]  D. Sosnowska,et al.  Age-Related Autoregulatory Dysfunction and Cerebromicrovascular Injury in Mice with Angiotensin II-induced Hypertension , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[71]  Hiroyuki Ito,et al.  Possible involvement of oxidative stress as a causative factor in blood-brain barrier dysfunction in stroke-prone spontaneously hypertensive rats. , 2013, Microvascular research.

[72]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[73]  Maja A. A. Binnewijzend,et al.  Specific risk factors for microbleeds and white matter hyperintensities in Alzheimer's disease , 2013, Neurobiology of Aging.

[74]  Farzaneh A. Sorond,et al.  Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people , 2013, Neurology.

[75]  D. Sosnowska,et al.  Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease. , 2013, American journal of physiology. Heart and circulatory physiology.

[76]  E. Siemers,et al.  A phase 3 trial of semagacestat for treatment of Alzheimer's disease. , 2013, The New England journal of medicine.

[77]  W. Freeman,et al.  Insulin-like growth factor-1 in CNS and cerebrovascular aging , 2013, Front. Aging Neurosci..

[78]  J. C. Torre.  Vascular risk factors: a ticking time bomb to Alzheimer's disease. , 2013 .

[79]  P. Fox,et al.  Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[80]  B. Winblad,et al.  VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival , 2013, Scientific Reports.

[81]  A. Dorrance,et al.  The effects of hypertension on the cerebral circulation. , 2013, American journal of physiology. Heart and circulatory physiology.

[82]  B. Zlokovic.  Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. , 2013, JAMA neurology.

[83]  D. Sosnowska,et al.  Aging‐induced dysregulation of Dicer1‐dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[84]  R. Weindruch,et al.  Circulating factors induced by caloric restriction in the non‐human primate Macaca mulatta activate angiogenic processes in endothelial cells , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[85]  Hope D. Anderson,et al.  Astrocyte-induced cortical vasodilation is mediated by D-serine and endothelial nitric oxide synthase , 2013, Proceedings of the National Academy of Sciences.

[86]  Tzeng-Ji Chen,et al.  Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population--a nationwide cohort study. , 2013, Circulation journal : official journal of the Japanese Circulation Society.

[87]  C. Iadecola,et al.  Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain , 2013, Stroke.

[88]  B. Zlokovic,et al.  Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[89]  J. Penninger,et al.  Impact of ACE2 Deficiency and Oxidative Stress on Cerebrovascular Function With Aging , 2012, Stroke.

[90]  J. Rossier,et al.  Impaired neurovascular coupling in the APPxPS1 mouse model of Alzheimer's disease. , 2012, Current Alzheimer research.

[91]  C. Sobey,et al.  Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain. , 2012, Journal of applied physiology.

[92]  B. Zlokovic,et al.  Hypertension Induces Brain &bgr;-Amyloid Accumulation, Cognitive Impairment, and Memory Deterioration Through Activation of Receptor for Advanced Glycation End Products in Brain Vasculature , 2012, Hypertension.

[93]  X. Tong,et al.  Age-Dependent Rescue by Simvastatin of Alzheimer's Disease Cerebrovascular and Memory Deficits , 2012, The Journal of Neuroscience.

[94]  C. Iadecola,et al.  Central Cardiovascular Circuits Contribute to the Neurovascular Dysfunction in Angiotensin II Hypertension , 2012, The Journal of Neuroscience.

[95]  D. Sosnowska,et al.  Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.

[96]  I. Skoog,et al.  Blood Pressure Trajectories From Midlife to Late Life in Relation to Dementia in Women Followed for 37 Years , 2012, Hypertension.

[97]  T. Deerinck,et al.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation , 2012, Nature Communications.

[98]  B. Zlokovic.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[99]  B. Zlokovic,et al.  Central nervous system pericytes in health and disease , 2011, Nature Neuroscience.

[100]  Venkatesh N. Murthy,et al.  Role of Astrocytes in Neurovascular Coupling , 2011, Neuron.

[101]  G. Lembo,et al.  'Alzheimer-like' pathology in a murine model of arterial hypertension. , 2011, Biochemical Society transactions.

[102]  E. Lakatta,et al.  Age‐associated vascular oxidative stress, Nrf2 dysfunction and NF‐κB activation in the non‐human primate Macaca mulatta , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[103]  V L Villemagne,et al.  Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease , 2011, Neurology.

[104]  D. Sosnowska,et al.  Liver‐specific knockdown of IGF‐1 decreases vascular oxidative stress resistance by impairing the Nrf2‐dependent antioxidant response , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.

[105]  R. de Cabo,et al.  Vascular oxidative stress in aging: a homeostatic failure due to dysregulation of Nrf2‐mediated antioxidant response , 2011, American journal of physiology. Heart and circulatory physiology.

[106]  Kevin Pearson,et al.  Adaptive induction of NF‐E2–Related Factor‐2‐driven antioxidant genes in endothelial cells in response to hyperglycemia , 2011, American journal of physiology. Heart and circulatory physiology.

[107]  W. Brown,et al.  Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.

[108]  Berislav V. Zlokovic,et al.  Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging , 2010, Neuron.

[109]  R. de Cabo,et al.  Mechanisms of vascular aging: new perspectives. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[110]  Jack C. de la Torre,et al.  Vascular risk factor detection and control may prevent Alzheimer's disease , 2010, Ageing Research Reviews.

[111]  D. Ingram,et al.  NOX activity in brain aging: exacerbation by high fat diet. , 2010, Free radical biology & medicine.

[112]  Luisa Minghetti,et al.  Role of neuroinflammation in hypertension-induced brain amyloid pathology , 2010, Neurobiology of Aging.

[113]  M. Zhang,et al.  Angiotensin II induced cerebral microvascular inflammation and increased blood–brain barrier permeability via oxidative stress , 2010, Neuroscience.

[114]  D. Ingram,et al.  Cognitive impairment following high fat diet consumption is associated with brain inflammation , 2010, Journal of Neuroimmunology.

[115]  D. Heistad,et al.  Spontaneous Intracerebral Hemorrhage during Acute and Chronic Hypertension in Mice , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[116]  L. Farrer,et al.  Hypertension Increases the Probability of Alzheimer’s Disease and of Mild Cognitive Impairment in an Arab Community in Northern Israel , 2009, Neuroepidemiology.

[117]  V. Hachinski,et al.  Changing perspectives regarding late-life dementia , 2009, Nature Reviews Neurology.

[118]  H. Tanila,et al.  Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[119]  P. Martínez-Martín,et al.  Role of Hypertension in Aggravating Aβ Neuropathology of AD Type and Tau-Mediated Motor Impairment , 2009, Cardiovascular psychiatry and neurology.

[120]  D. Ingram,et al.  Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: Contributions of maternal diet , 2009, Neurobiology of Disease.

[121]  C. Sigmund,et al.  Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. , 2009, American journal of physiology. Heart and circulatory physiology.

[122]  L. Liaudet,et al.  The macrocirculation and microcirculation of hypertension , 2009, Current hypertension reports.

[123]  Edith Hamel,et al.  Pathway-Specific Variations in Neurovascular and Neurometabolic Coupling in Rat Primary Somatosensory Cortex , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[124]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[125]  C. Iadecola,et al.  Threats to the Mind: Aging, Amyloid, and Hypertension , 2009, Stroke.

[126]  Pedro Rosa-Neto,et al.  Complete Rescue of Cerebrovascular Function in Aged Alzheimer's Disease Transgenic Mice by Antioxidants and Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist , 2008, The Journal of Neuroscience.

[127]  B. Shukitt-Hale,et al.  B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice , 2008, Proceedings of the National Academy of Sciences.

[128]  Gregory M. Szilagyi,et al.  Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. , 2008, Archives of neurology.

[129]  Saul Wilson,et al.  Oxidative Stress through Activation of NAD(P)H Oxidase in Hypertensive Mice with Spontaneous Intracranial Hemorrhage , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[130]  Joy W. Chang,et al.  Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction , 2008, Proceedings of the National Academy of Sciences.

[131]  O. Lopez,et al.  Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[132]  Ping Zhou,et al.  Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein , 2008, Proceedings of the National Academy of Sciences.

[133]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[134]  M. Verbeek,et al.  Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. , 2007, The American journal of pathology.

[135]  C. Iadecola,et al.  Nox2-Derived Reactive Oxygen Species Mediate Neurovascular Dysregulation in the Aging Mouse Brain , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[136]  Phillip B. Jones,et al.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.

[137]  J. Wardlaw,et al.  Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. , 2007, Brain : a journal of neurology.

[138]  Z. Ungvari,et al.  Increased mitochondrial H2O2 production promotes endothelial NF- B activation in aged rat arteries , 2007 .

[139]  C. Iadecola,et al.  Cerebrovascular Nitrosative Stress Mediates Neurovascular and Endothelial Dysfunction Induced by Angiotensin II , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[140]  I. Skoog,et al.  Update on hypertension and Alzheimer's disease , 2006, Neurological research.

[141]  C. Iadecola,et al.  Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2–Derived Radicals , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[142]  Hiroshi Matsuda,et al.  The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT , 2005, NeuroImage.

[143]  M. Štrucl,et al.  Age-related changes in the relationship between visual evoked potentials and visually evoked cerebral blood flow velocity response. , 2005, Functional neurology.

[144]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[145]  C. Iadecola,et al.  Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase–Derived Radicals , 2004, Circulation research.

[146]  Carole Dufouil,et al.  The Association Between Blood Pressure, Hypertension, and Cerebral White Matter Lesions: Cardiovascular Determinants of Dementia Study , 2004, Hypertension.

[147]  Rhoda Au,et al.  Cerebral Microbleeds: Prevalence and Associations With Cardiovascular Risk Factors in the Framingham Study , 2004, Stroke.

[148]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[149]  Z. Ungvari,et al.  Proinflammatory phenotype of coronary arteries promotes endothelial apoptosis in aging. , 2004, Physiological genomics.

[150]  C. Iadecola,et al.  Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex. , 2003, American journal of physiology. Heart and circulatory physiology.

[151]  David R. Riddle,et al.  Microvascular plasticity in aging , 2003, Ageing Research Reviews.

[152]  J. Cano,et al.  Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia , 2003, Journal of neurochemistry.

[153]  C. Iadecola,et al.  Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. , 2002, American journal of physiology. Heart and circulatory physiology.

[154]  Z. Ungvari,et al.  Aging-Induced Phenotypic Changes and Oxidative Stress Impair Coronary Arteriolar Function , 2002, Circulation research.

[155]  T. Wisniewski,et al.  Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. , 2002, Vascular pharmacology.

[156]  D. Sane,et al.  Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system. , 2002, Cardiovascular research.

[157]  George A. Carlson,et al.  Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.

[158]  D. Cornfield,et al.  Aβ-peptides enhance vasoconstriction in cerebral circulation , 2001 .

[159]  M. Witter,et al.  Functional MR imaging in Alzheimer's disease during memory encoding. , 2000, AJNR. American journal of neuroradiology.

[160]  P. Luiten,et al.  Similar Ultrastructural Breakdown of Cerebrocortical Capillaries in Alzheimer's Disease, Parkinson's Disease, and Experimental Hypertension: What is the Functional Link? , 2000, Annals of the New York Academy of Sciences.

[161]  W. Markesbery,et al.  Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆ , 2000, Neurobiology of Aging.

[162]  R. Havlik,et al.  Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.

[163]  P Kapeller,et al.  MRI evidence of past cerebral microbleeds in a healthy elderly population , 1999, Neurology.

[164]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[165]  C. Mathiesen,et al.  Modification of activity‐dependent increases of cerebral blood flow by excitatory synaptic activity and spikes in rat cerebellar cortex , 1998, The Journal of physiology.

[166]  J. Bading,et al.  Cerebrovascular Accumulation and Increased Blood‐Brain Barrier Permeability to Circulating Alzheimer's Amyloid β Peptide in Aged Squirrel Monkey with Cerebral Amyloid Angiopathy , 1998, Journal of neurochemistry.

[167]  P. Hutchins,et al.  Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. , 1997, Endocrinology.

[168]  A. Villringer,et al.  Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS) — correlation with simultaneous rCBF-PET measurements , 1997, Brain Research.

[169]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[170]  P. R. Hof,et al.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders , 1994, Acta Neuropathologica.

[171]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[172]  S M Blinkov,et al.  Rarefication of the arterioles and capillary network in the brain of rats with different forms of hypertension. , 1985, Microvascular research.

[173]  H. Bohlen,et al.  Microvascular adaptation in the cerebral cortex of adult spontaneously hypertensive rats. , 1984, Hypertension.

[174]  D. Heistad,et al.  Effect of Chronic Hypertension on the Blood‐Brain Barrier , 1980, Hypertension.

[175]  J. Patterson,et al.  Responses of cerebral arteries and arterioles to acute hypotension and hypertension. , 1978, The American journal of physiology.

[176]  S. Tarantini,et al.  Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging. , 2017, American journal of physiology. Heart and circulatory physiology.

[177]  J. C. Torre.  Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations , 2017 .

[178]  J. Baur,et al.  Small Vessels – Big Problems : Novel Insights into Microvascular Mechanisms of Diseases Purinergic glio-endothelial coupling during neuronal activity : role of P 2 Y 1 receptors and eNOS in functional hyperemia in the mouse somatosensory cortex , 2015 .

[179]  Joep Lagro,et al.  Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer's disease. , 2014, Current Alzheimer research.

[180]  K. Fassbender,et al.  Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease. , 2014, Current Alzheimer research.

[181]  J. Attems,et al.  Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. , 2014, Journal of Alzheimer's disease : JAD.

[182]  C. Laske.  Phase 3 trials of solanezumab and bapineuzumab for Alzheimer's disease. , 2014, The New England journal of medicine.

[183]  D. Sosnowska,et al.  Pathophysiology of Hypertension Role of 20-HETE , TRPC channels , and BKCa in dysregulation of pressure-induced Ca 2 signaling and myogenic constriction of cerebral arteries in aged hypertensive mice , 2013 .

[184]  J. C. Torre.  Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. , 2012 .

[185]  D. Bennett,et al.  AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia , 2011 .

[186]  W. Brown.  A review of string vessels or collapsed, empty basement membrane tubes. , 2010, Journal of Alzheimer's disease : JAD.

[187]  C. Iadecola,et al.  Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. , 2006, Journal of applied physiology.

[188]  Ping Zhou,et al.  NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[189]  V. Fischer,et al.  Altered angioarchitecture in selected areas of brains with Alzheimer's disease , 2004, Acta Neuropathologica.

[190]  N. Sakata,et al.  Pathologic evidence of microvascular rarefaction in the brain of renal hypertensive rats. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[191]  B. Winblad,et al.  Blood pressure and dementia in persons 75+ years old: 3-year follow-up results from the Kungsholmen Project. , 2001, Journal of Alzheimer's disease : JAD.

[192]  D. Selkoe,et al.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. , 1992, The American journal of pathology.